In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
After finishing at $1.54 in the prior trading day, Protalix BioTherapeutics Inc (AMEX: PLX) closed at $1.47, down -4.55%. In other words, the price has decreased by -$4.55 from its previous closing price. On the day, 0.86 million shares were traded. PLX stock price reached its highest trading level at $1.54 during the session, while it also had its lowest trading level at $1.455.
Ratios:
Our goal is to gain a better understanding of PLX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.69 and its Current Ratio is at 2.49. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on June 08, 2020, Reiterated its Buy rating but revised its target price to $11 from $3 previously.
On April 17, 2017, Rodman & Renshaw reiterated its Buy rating and also lowered its target price recommendation from $4 to $5.
On April 04, 2016, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $3.50.Rodman & Renshaw initiated its Buy rating on April 04, 2016, with a $3.50 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PLX now has a Market Capitalization of 117022448 and an Enterprise Value of 88311528. As of this moment, Protalix’s Price-to-Earnings (P/E) ratio for their current fiscal year is 35.00, and their Forward P/E ratio for the next fiscal year is 3.27. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.96 while its Price-to-Book (P/B) ratio in mrq is 2.54. Its current Enterprise Value per Revenue stands at 1.478 whereas that against EBITDA is 14.827.
Stock Price History:
The Beta on a monthly basis for PLX is -0.21, which has changed by 0.36111116 over the last 52 weeks, in comparison to a change of 0.11708844 over the same period for the S&P500. Over the past 52 weeks, PLX has reached a high of $3.10, while it has fallen to a 52-week low of $0.82. The 50-Day Moving Average of the stock is -20.49%, while the 200-Day Moving Average is calculated to be -22.12%.
Shares Statistics:
The stock has traded on average 1.12M shares per day over the past 3-months and 1900070 shares per day over the last 10 days, according to various share statistics. A total of 78.13M shares are outstanding, with a floating share count of 73.81M. Insiders hold about 7.28% of the company’s shares, while institutions hold 10.98% stake in the company. Shares short for PLX as of 1749772800 were 1187764 with a Short Ratio of 1.06, compared to 1747267200 on 979395. Therefore, it implies a Short% of Shares Outstanding of 1187764 and a Short% of Float of 1.5599999999999998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
